Anson’s Executive Chairman and CEO, Bruce Richardson, commented: “Anson is
focused on the development of the Paradox Brine Project while at the same time continuing
to make progress on other projects that it has in its portfolio as part of its multimineral/multi-revenue strategy. The recent increase in the uranium price has been
expected for some time and as Anson has continued to invest in the development of the
Yellow Cat Project, it is well positioned to take advantage of the renewed interest in this
mineral. These high grade assay results and a data base that provides a detailed
understanding of the geological setting, provides further opportunity to increase the project
exploration target. The Company is continuing to develop the Yellow Cat project through
the next stage of its exploration program with the aim of increasing shareholder value
- Forums
- ASX - By Stock
- Ann: Yellow Cat Assays Confirms High Grade Uranium & Vanadium
Anson’s Executive Chairman and CEO, Bruce Richardson, commented:...
Featured News
Add ASN (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.6¢ |
Change
0.001(1.54%) |
Mkt cap ! $91.38M |
Open | High | Low | Value | Volume |
6.8¢ | 6.8¢ | 6.3¢ | $95.22K | 1.446M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 6.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.6¢ | 205209 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.065 |
2 | 8935 | 0.064 |
1 | 100000 | 0.063 |
1 | 16129 | 0.062 |
4 | 94195 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.066 | 205209 | 1 |
0.067 | 62500 | 1 |
0.068 | 285970 | 2 |
0.070 | 179014 | 2 |
0.071 | 3000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
ASN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online